Skip to main content

Table 3 Overall results and sensitivity analysis

From: Polyunsaturated fatty acid intake and incidence of type 2 diabetes in adults: a dose response meta-analysis of cohort studies

Indicators

Summary RR (95% CI)

p

I2 (%)

Total PUFA

1.012 (0.992, 1.032)

0.246

68.2

 Sensitivity analysis

1.012 (0.992, 1.032)

  

 Publication bias

Z = 2.46

0.014

 

Sex

 Women

1.049 (1.019, 1.079)

0.001

77.1

 Men

0.955 (0.913, 0.999)

0.044

62.2

 Mixed

0.984 (0.955, 1.013)

0.269

41.2

Geographic location

 United States

1.011 (0.982, 1.041)

0.467

78.2

 Europe

1.040 (1.009, 1.072)

0.012

54.8

 Australia

1.188 (1.113, 1.269)

< 0.001

0.0

 Asia

0.897 (0.860, 0.936)

< 0.001

45.4

Duration of follow-up, y

 < 10

0.999 (0.968, 1.031)

0.942

38.4

 ≥ 10

1.016 (0.991, 1.042)

0.200

79.2

Exposure

 PUFA

0.979 (0.905, 1.058)

0.588

63.7

 Omega-3

1.028 (0.987,1.070)

0.183

69.0

 Omega-6

0.985 (0.942, 1.030)

0.511

60.7

 ALA

1.003 (0.966, 1.041)

0.887

59.2

 EPA

1.078 (0.965, 1.203)

0.183

64.9

 DHA

1.164 (1.048, 1.294)

0.005

61.4

 EPA + DHA

0.992 (0.926, 1.064)

0.830

0.0

 LA

0.956 (0.930, 0.983)

0.001

40.4

 AA

1.286 (0.964, 1.716)

0.087

92.5

  1. RR relative risk, PUFA polyunsaturated fatty acid, ALA alpha linolenic acid, EPA eicosapentaenoic acid, DHA docosahexaenoic acid, LA linoleic acid, AA arachidonic acid